JP Stock MarketDetailed Quotes

3204 Toabo

Watchlist

413
-3-0.72%

20min DelayNot Open Dec 16 15:30 JST

3.69BMarket Cap6.42P/E (Static)

Toabo Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-9.71%4.42B

-4.27%4.35B

12.01%19.04B

16.37%5.13B

1.25%4.47B

16.26%4.89B

14.65%4.55B

9.45%17B

4.21%4.41B

12.40%4.42B

Cost of revenue

-10.35%3.58B

-5.84%3.47B

11.61%15.43B

14.90%4.13B

1.43%3.62B

16.30%3.99B

14.25%3.68B

9.87%13.82B

3.72%3.6B

10.83%3.57B

Gross profit

-6.77%840M

2.31%886M

13.72%3.62B

22.60%998M

0.59%850M

16.11%901M

16.40%866M

7.65%3.18B

6.54%814M

19.35%845M

Operating expense

1.21%751M

6.61%710M

7.85%2.87B

7.81%745M

8.45%719M

11.92%742M

3.10%666M

2.66%2.66B

0.73%691M

4.91%663M

Operating profit

-44.03%89M

-12.00%176M

43.99%743M

105.69%253M

-28.02%131M

40.71%159M

104.08%200M

43.73%516M

57.69%123M

139.47%182M

Net non-operating interest income (expenses)

-38.89%-25M

-28.57%-18M

-9.38%-70M

-17.65%-20M

-12.50%-18M

6.67%-14M

9.86%-64M

0.00%-17M

15.79%-16M

Non-operating interest income

0.00%5M

0.00%4M

0.00%18M

0.00%4M

0.00%5M

0.00%4M

38.46%18M

0.00%4M

66.67%5M

Non-operating interest expense

30.43%30M

22.22%22M

7.32%88M

14.29%24M

9.52%23M

-5.26%18M

-2.38%82M

0.00%21M

-4.55%21M

Net investment income

173M

16M

19.72%85M

47.06%-9M

157.14%36M

7.58%71M

-165.38%-17M

100.00%14M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-81.82%2M

-106.25%-1M

0.00%11M

433.33%16M

Income from associates and other participating interests

-150.00%-1M

-25.00%-5M

200.00%2M

150.00%2M

50.00%-4M

10.00%-9M

266.67%5M

-100.00%-2M

Special income (charges)

-16.67%-21M

-305.17%-235M

-264.71%-186M

-357.14%-32M

-1,700.00%-18M

0.00%1M

-286.67%-58M

-610.00%-51M

66.67%-7M

Less:Other special charges

----

92.86%108M

22.45%60M

--32M

--17M

0.00%-1M

273.33%56M

590.00%49M

----

Less:Write off

----

6,250.00%127M

6,200.00%126M

--0

----

--2M

--0

Other non-operating income (expenses)

-3M

933.33%31M

-650.00%-11M

-1,850.00%-39M

-25.00%3M

-94.59%2M

50.00%-2M

Income before tax

19.66%213M

7.03%198M

9.40%512M

-12.87%149M

19.46%178M

105.56%185M

23.48%468M

-37.63%58M

140.85%171M

Income tax

11.29%69M

-1.22%81M

-130.15%-60M

-26,800.00%-267M

-13.70%63M

-11.43%62M

49.09%82M

64.46%199M

104.00%1M

92.11%73M

Net income

23.08%144M

14.71%117M

113.01%573M

362.07%268M

-11.34%86M

48.10%117M

191.43%102M

4.26%269M

-50.85%58M

193.94%97M

Net income continuous operations

24.14%144M

13.59%117M

112.64%572M

368.42%267M

-12.24%86M

46.84%116M

194.29%103M

4.26%269M

-51.69%57M

196.97%98M

Noncontrolling interests

Net income attributable to the company

24.14%144M

12.62%116M

113.01%573M

362.07%268M

-11.34%86M

46.84%116M

194.29%103M

4.26%269M

-50.43%58M

223.33%97M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

24.14%144M

12.62%116M

113.01%573M

362.07%268M

-11.34%86M

46.84%116M

194.29%103M

4.26%269M

-50.43%58M

223.33%97M

Gross dividend payment

Basic earnings per share

24.81%16.3

13.48%13.13

113.02%64.29

367.08%30.08

-12.19%9.58

46.91%13.06

193.65%11.57

4.00%30.18

-51.14%6.44

228.61%10.91

Diluted earnings per share

25.31%16.3

13.48%13.13

113.02%64.29

366.65%30.0523

-11.92%9.58

46.84%13.0072

193.65%11.57

4.00%30.18

-50.91%6.44

227.61%10.8766

Dividend per share

9.09%12

10.00%11

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	-9.71%4.42B	-4.27%4.35B	12.01%19.04B	16.37%5.13B	1.25%4.47B	16.26%4.89B	14.65%4.55B	9.45%17B	4.21%4.41B	12.40%4.42B
Cost of revenue	-10.35%3.58B	-5.84%3.47B	11.61%15.43B	14.90%4.13B	1.43%3.62B	16.30%3.99B	14.25%3.68B	9.87%13.82B	3.72%3.6B	10.83%3.57B
Gross profit	-6.77%840M	2.31%886M	13.72%3.62B	22.60%998M	0.59%850M	16.11%901M	16.40%866M	7.65%3.18B	6.54%814M	19.35%845M
Operating expense	1.21%751M	6.61%710M	7.85%2.87B	7.81%745M	8.45%719M	11.92%742M	3.10%666M	2.66%2.66B	0.73%691M	4.91%663M
Operating profit	-44.03%89M	-12.00%176M	43.99%743M	105.69%253M	-28.02%131M	40.71%159M	104.08%200M	43.73%516M	57.69%123M	139.47%182M
Net non-operating interest income (expenses)	-38.89%-25M	-28.57%-18M	-9.38%-70M	-17.65%-20M	-12.50%-18M	-12.50%-18M	6.67%-14M	9.86%-64M	0.00%-17M	15.79%-16M
Non-operating interest income	0.00%5M	0.00%4M	0.00%18M	0.00%4M	0.00%5M	0.00%5M	0.00%4M	38.46%18M	0.00%4M	66.67%5M
Non-operating interest expense	30.43%30M	22.22%22M	7.32%88M	14.29%24M	9.52%23M	9.52%23M	-5.26%18M	-2.38%82M	0.00%21M	-4.55%21M
Net investment income	173M	16M	19.72%85M	47.06%-9M	157.14%36M			7.58%71M	-165.38%-17M	100.00%14M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	0	0	-81.82%2M	-106.25%-1M	3M	0	0	0.00%11M	433.33%16M	0
Income from associates and other participating interests	-150.00%-1M	-25.00%-5M	0	0	200.00%2M	150.00%2M	50.00%-4M	10.00%-9M	266.67%5M	-100.00%-2M
Special income (charges)	-16.67%-21M	0	-305.17%-235M	-264.71%-186M	-357.14%-32M	-1,700.00%-18M	0.00%1M	-286.67%-58M	-610.00%-51M	66.67%-7M
Less:Other special charges	----	----	92.86%108M	22.45%60M	--32M	--17M	0.00%-1M	273.33%56M	590.00%49M	----
Less:Write off	----	----	6,250.00%127M	6,200.00%126M	--0	----	----	--2M	--2M	--0
Other non-operating income (expenses)	-3M	933.33%31M	-650.00%-11M	-1,850.00%-39M			-25.00%3M	-94.59%2M	50.00%-2M	0
Income before tax	19.66%213M	7.03%198M	9.40%512M	0	-12.87%149M	19.46%178M	105.56%185M	23.48%468M	-37.63%58M	140.85%171M
Income tax	11.29%69M	-1.22%81M	-130.15%-60M	-26,800.00%-267M	-13.70%63M	-11.43%62M	49.09%82M	64.46%199M	104.00%1M	92.11%73M
Net income	23.08%144M	14.71%117M	113.01%573M	362.07%268M	-11.34%86M	48.10%117M	191.43%102M	4.26%269M	-50.85%58M	193.94%97M
Net income continuous operations	24.14%144M	13.59%117M	112.64%572M	368.42%267M	-12.24%86M	46.84%116M	194.29%103M	4.26%269M	-51.69%57M	196.97%98M
Noncontrolling interests	1M	0	0	0	0	0	0	0	0	0
Net income attributable to the company	24.14%144M	12.62%116M	113.01%573M	362.07%268M	-11.34%86M	46.84%116M	194.29%103M	4.26%269M	-50.43%58M	223.33%97M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	24.14%144M	12.62%116M	113.01%573M	362.07%268M	-11.34%86M	46.84%116M	194.29%103M	4.26%269M	-50.43%58M	223.33%97M
Gross dividend payment
Basic earnings per share	24.81%16.3	13.48%13.13	113.02%64.29	367.08%30.08	-12.19%9.58	46.91%13.06	193.65%11.57	4.00%30.18	-51.14%6.44	228.61%10.91
Diluted earnings per share	25.31%16.3	13.48%13.13	113.02%64.29	366.65%30.0523	-11.92%9.58	46.84%13.0072	193.65%11.57	4.00%30.18	-50.91%6.44	227.61%10.8766
Dividend per share	0	0	9.09%12	9.09%12	0	0	0	10.00%11	10.00%11	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

See the daily top gainer.